These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 29760406

  • 1. LncRNA PVT1 regulates triple-negative breast cancer through KLF5/beta-catenin signaling.
    Tang J, Li Y, Sang Y, Yu B, Lv D, Zhang W, Feng H.
    Oncogene; 2018 Aug; 37(34):4723-4734. PubMed ID: 29760406
    [Abstract] [Full Text] [Related]

  • 2. Effect of lncRNA PVT1/miR186/KLF5 Axis on the Occurrence and Progression of Cholangiocarcinoma.
    Sun Q, Gong X, Wu J, Hu Z, Zhang Q, Gong J, Zhu X.
    Biomed Res Int; 2021 Aug; 2021():8893652. PubMed ID: 34337058
    [Abstract] [Full Text] [Related]

  • 3. Kynurenine 3-monooxygenase upregulates pluripotent genes through β-catenin and promotes triple-negative breast cancer progression.
    Huang TT, Tseng LM, Chen JL, Chu PY, Lee CH, Huang CT, Wang WL, Lau KY, Tseng MF, Chang YY, Chiang TY, Ueng YF, Lee HC, Dai MS, Liu CY.
    EBioMedicine; 2020 Apr; 54():102717. PubMed ID: 32268268
    [Abstract] [Full Text] [Related]

  • 4. PVT1 affects EMT and cell proliferation and migration via regulating p21 in triple-negative breast cancer cells cultured with mature adipogenic medium.
    Wang L, Wang R, Ye Z, Wang Y, Li X, Chen W, Zhang M, Cai C.
    Acta Biochim Biophys Sin (Shanghai); 2018 Dec 01; 50(12):1211-1218. PubMed ID: 30371726
    [Abstract] [Full Text] [Related]

  • 5. Long noncoding RNA GAS5 suppresses triple negative breast cancer progression through inhibition of proliferation and invasion by competitively binding miR-196a-5p.
    Li S, Zhou J, Wang Z, Wang P, Gao X, Wang Y.
    Biomed Pharmacother; 2018 Aug 01; 104():451-457. PubMed ID: 29793177
    [Abstract] [Full Text] [Related]

  • 6. CCAT1 promotes triple-negative breast cancer progression by suppressing miR-218/ZFX signaling.
    Han C, Li X, Fan Q, Liu G, Yin J.
    Aging (Albany NY); 2019 Jul 16; 11(14):4858-4875. PubMed ID: 31310241
    [Abstract] [Full Text] [Related]

  • 7. miR-217 inhibits triple-negative breast cancer cell growth, migration, and invasion through targeting KLF5.
    Zhou W, Song F, Wu Q, Liu R, Wang L, Liu C, Peng Y, Mao S, Feng J, Chen C.
    PLoS One; 2017 Jul 16; 12(4):e0176395. PubMed ID: 28437471
    [Abstract] [Full Text] [Related]

  • 8. LncRNA DANCR upregulates PI3K/AKT signaling through activating serine phosphorylation of RXRA.
    Tang J, Zhong G, Zhang H, Yu B, Wei F, Luo L, Kang Y, Wu J, Jiang J, Li Y, Wu S, Jia Y, Liang X, Bi A.
    Cell Death Dis; 2018 Dec 05; 9(12):1167. PubMed ID: 30518934
    [Abstract] [Full Text] [Related]

  • 9. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
    Zhao J, Du P, Cui P, Qin Y, Hu C, Wu J, Zhou Z, Zhang W, Qin L, Huang G.
    Oncogene; 2018 Jul 05; 37(30):4094-4109. PubMed ID: 29706652
    [Abstract] [Full Text] [Related]

  • 10. DANCR Induces Cisplatin Resistance of Triple-Negative Breast Cancer by KLF5/p27 Signaling.
    Su A, Yao K, Zhang H, Wang Y, Zhang H, Tang J.
    Am J Pathol; 2023 Mar 05; 193(3):248-258. PubMed ID: 36509121
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Epigenetic regulation of triple negative breast cancer (TNBC) by TGF-β signaling.
    Vishnubalaji R, Alajez NM.
    Sci Rep; 2021 Jul 29; 11(1):15410. PubMed ID: 34326372
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA MALAT1 promotes proliferation and invasion via targeting miR-129-5p in triple-negative breast cancer.
    Zuo Y, Li Y, Zhou Z, Ma M, Fu K.
    Biomed Pharmacother; 2017 Nov 29; 95():922-928. PubMed ID: 28915533
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Reduced lncRNA Aim enhances the malignant invasion of triple-negative breast cancer cells mainly by activating Wnt/β-catenin/mTOR/PI3K signaling.
    Liu L, Yu D, Shi H, Li J, Meng L.
    Pharmazie; 2017 Oct 01; 72(10):599-603. PubMed ID: 29441885
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.